Micafungin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70771-1683

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Micafungin (NDC 70771-1683). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50 mg Per Vial Carton (4a44243c B3ef 4372 8084 914b28e38d84 01)

Packaging label for Micafungin for Injection 50 mg/vial, a lyophilized powder for solution administered via intravenous infusion. The label indicates sterile, nonpyrogenic single-dose vials with 50 mg micafungin per vial. It is manufactured by Zydus Lifesciences Limited and includes storage and usage instructions.*

FDA Label Image

100 mg Per Vial Carton (4a44243c B3ef 4372 8084 914b28e38d84 02)

Micafungin for Injection 100 mg/vial lyophilized powder for solution, intended for intravenous infusion only. The label shows 10 x 100 mg single-dose vials per package. Manufactured by Zydus Lifesciences Ltd., Vadodara, India, with instructions to discard unused portion and store at 25°C (77°F). The label includes dosing information per vial and cautions against using bacteriostatic agent for reconstitution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.